OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications
Zilu Cheng, Huikuan Chu, Qingjing Zhu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 15

Showing 15 citing articles:

Sodium aescinate-induced hepatotoxicity via ATF4/GSH/GPX4 axis-mediated ferroptosis
Xi Chen, Jie Zhou, Xin Zheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11

Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5

Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 56-56
Open Access

18beta-glycyrrhetinic acid alleviates deoxynivalenol-induced hepatotoxicity by inhibiting GPX4-dependent ferroptosis
Chenchen Song, Wei Wang, Yu Hua, et al.
Toxicon (2025), pp. 108228-108228
Closed Access

Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access

A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
M. Hong Nguyen, Andrew Lian, Frederick T. Guilford, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 644-644
Open Access

Yunnan medicine Jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy
Xin Hong, Haijing Liu, Hongli Sun, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access

The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
И. В. Холоденко, Р. В. Холоденко, K. N. Yarygin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15212-15212
Open Access | Times Cited: 7

Improving understanding of ferroptosis: molecular mechanisms, connection with cellular senescence and implications for aging
Diego De León-Oliva, Diego Liviu Boaru, Ana Minaya‐Bravo, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39684-e39684
Open Access | Times Cited: 1

Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway
Ji Zhu, Jianan Guo, Zhijun Liu, et al.
Chemico-Biological Interactions (2024) Vol. 400, pp. 111162-111162
Closed Access

HMOX1 Inhibits Ferroptosis in Non-Alcoholic Fatty Liver Disease
Yao Li, Jun Zou, Xinze Qiu, et al.
Research Square (Research Square) (2024)
Open Access

Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice
Gi-Cheol Park, Soo-Young Bang, Ji Min Kim, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1336-1336
Open Access

Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia
Jakub Rogalski, Oliwia Gawlik-Kotelnicka, Tomasz Tomczak
Current Problems of Psychiatry (2024) Vol. 25, pp. 226-238
Open Access

Page 1

Scroll to top